Projects funded by the NCN
Small molecule modulators of the tumor necrosis factor alpha signaling pathway for the inhibition of inflammatory processes and the enhancement of cancer immunotherapy
2024/53/B/NZ7/02591
Keywords:
TNF PD-L1 LYTAC targeted protein degradation chemical probe immune system cancer inflammation
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
- ST5_14: Other related subjects
- NZ1_2: Biochemistry
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Principal investigator (from the host institution):
Number of co-investigators in the project: 6
Call: OPUS 27 - announced on 2024-03-21
Amount awarded: 3 892 870 PLN
Project start date (Y-m-d): 2025-03-03
Project end date (Y-m-d): 2028-03-02
Project duration:: 36 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.